Edwin Stone News Today

Cellular Origins and the Cell and Gene Therapy Catapult (CGT Catapult) have announced a new collaboration to demonstrate universal automation of CGT manufacturing.

Partnership to develop and implement Cellular Origins' robotic platform Constellation for universal automation of CGT manufacturing at CGT Catapult's Stevenage Manufacturing Innovation Centre Cellular

TTP Company Cellular Origins has appointed Peter Crossley as Chief Operating Officer (COO), to bolster Cellular Origins’ mission to develop scalable automation solutions for cell therapy manufacture. Click to read more...

Rob Hage was a patient at the University of Iowa Institute for Vision Research and is now using his brewery Blind Butcher Brewery in Iowa and nonprofit BREWS for BLiNDNESS to raise money for future patients’ treatment. Hage was diagnosed in 2009 with a hereditary eye disease called retinitis pigmentosa. All of the proceeds for...

Closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labour by 51% and 16-fold

Partnership aims to integrate ScaleReady's CGT manufacturing workflow with Cellular Origins' robotic technology Initially focussed on automation of ScaleReady's G-Rex platform Cellular Origins

Cellular Origins a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs).

/PRNewswire/ -- In 2020 a family in northwest Iowa began making their own craft beer as a hobby during the pandemic. Those efforts took a serious turn when the...

New company created to enable commercial manufacture of new cell and gene therapies Cellular Origins' proprietary technology will address current barriers associated with cost-effective and

New company created to enable commercial manufacture of new cell and gene therapies.